Viewing Study NCT05172518


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-04-05 @ 8:46 PM
Study NCT ID: NCT05172518
Status: NOT_YET_RECRUITING
Last Update Posted: 2021-12-29
First Post: 2021-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
None Locally Advanced or Metastatic Breast Cancer View
Keywords: